EGFR and Its Role in Colorectal Cancer
Colorectal cancer is one of the most common and fatal types of cancers which congregates in the colon or rectum regions of the body. One of the ligand-receptor complexes that plays a major role in the progress of colorectal cancer includes the epidermal growth factor receptor (EGFR). EGFR is expressed on the cellular surface of a variety of cells such as epithelial and muscle cells. Upon binding to a ligand, the overall EGF-EGFR complex leads to a cascade of signaling within the cell to ultimately allow for multiple cellular functions including proliferation, differentiation, and dedifferentiation. When the EGFR activation is overexpressed, it can lead to colorectal cancer. Currently, there are many investigations aiming to study how the complex can be manipulated especially through inhibitors and antibodies to reverse the advancement of colorectal cancer. This chapter aims to understand the EGF-EGFR complex and explore the current research studies investigating EGFR and its role on colorectal cancer.
KeywordsEGF EGFR Colorectal cancer
- 1.What Is Colorectal Cancer? (n.d.) Retrieved October 10, 2017, from https://www.cancer.org/cancer/colon-rectal-cancer/about/what-is-colorectal-cancer.html
- 9.Spano J-P, Lagorce C, Atlan D, Milano G, Domont J, Benamouzig R, Attar A, Benichou J, Martin A, Morere J-F, Raphael M, Penault-Llorca F, Breau J-L, Fagard R, Khayat D, Wind P (2005) Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol 16(1):102–108. https://doi.org/10.1093/annonc/mdi006 CrossRefPubMedGoogle Scholar
- 12.Zampino MG, Magni E, Massacesi C, Zaniboni A, Martignetti A, Zorzino L, Braud FD (2007) First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer. Cancer 110(4):752–758. https://doi.org/10.1002/cncr.22851 CrossRefPubMedGoogle Scholar
- 14.Dougherty U, Mustafi R, Valuckaite V, Konda VJ, Pekow J, Sadiq F, Haider HI, Adhikari S, Hart J, Joseph L et al (2015) Western diet up-regulates ADAM17, a key meditator of EGFR signaling via activation of colonic renin-angiotensin system and inhibition of miR-145,-148a and -152. Gastroenterology 148:S–99Google Scholar
- 15.Fisher GA, Kuo T, Ramsey M, Schwartz E, Rouse RV, Cho CD, Sikic BI (2008) A phase II study of gefitinib, 5-fluorouracil, leucovorin, and oxaliplatin in previously untreated patients with metastatic colorectal cancer. Clin Cancer Res 14(21):7074–7079. https://doi.org/10.1158/1078-0432.ccr-08-1014 CrossRefPubMedPubMedCentralGoogle Scholar